PhRMA

New report shows more than 220 drugs in pipeline for diabetes

Thursday, November 15, 2012 08:00 AM

America's biopharmaceutical research companies currently are developing 221 innovative new medicines to help the nearly 26 million patients in the U.S. affected by diabetes.

More... »

Society for Clinical Research Sites launches as voice of site community in shaping research enterprise

Sunday, October 14, 2012 07:00 AM

Clinical research sites now have their first-ever trade group.

More... »

PhRMA reports nearly 1,000 medicines in development to fight cancer

Monday, June 4, 2012 06:00 PM

Pharmaceutical Research and Manufacturers of America (PhRMA) has released a report on American biopharmaceutical research companies’ 981 medicines and vaccines currently in development to fight the many types of cancer affecting millions of patients worldwide.

More... »

PhRMA member companies invested $49.5 billion in R&D in 2011

Tuesday, April 17, 2012 06:36 AM

Investment in research and development by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) remained strong at $49.5 billion in 2011, as the sector adapts to meet the challenges of evolving science, a changing marketplace and a difficult economic environment.

More... »

PhRMA: 54 drugs in development for COPD

Tuesday, February 7, 2012 10:07 AM

America’s biopharmaceutical research companies are working on 54 medicines to treat chronic obstructive pulmonary disease (COPD), according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

PhRMA issues statement on biosimilar user fees

Thursday, December 8, 2011 10:20 AM

Pharmaceutical Research and Manufacturers of America (PhRMA) vice president Sascha Haverfield-Gross has issued the following statement about user fees for biosimilars:

More... »

Nearly 90 medicines and vaccines in development for HIV/AIDS

Friday, December 2, 2011 03:51 PM

America’s biopharmaceutical research companies are testing 88 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

Concerns grow over CMS missing Sunshine Act draft deadline as data collection start date looms

Monday, October 17, 2011 08:02 AM

Industry groups have expressed concern about the Centers for Medicare and Medicaid Services (CMS) missing its deadline for drafting regulations to implement the so-called sunshine law, which requires sponsors to publicly disclose payments to physicians and teaching hospitals. Pharmaceutical and biotechnology companies must begin collecting data to comply with the law in less than 11 weeks.

More... »

Pharmas eagerly await FDA guidance on social media

Thursday, April 7, 2011 11:01 AM

As the FDA further delays its eagerly-awaited draft guidance on social media, U.S. drugmakers have pointed to the "incredible potential public health benefits" of using electronic media in health care, according to Pharma Times.

More... »

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Monday, February 7, 2011 07:00 AM

A billion-dollar U.S. government drug development center, which will focus on moving potential new discoveries out of the lab and into early-phase trials, could help biopharmaceutical companies improve their success rate in developing new treatments by reducing the risk of failure in early-stage research.

More... »